載入...
Acquired Resistance to Antiangiogenic Therapies in Hepatocellular Carcinoma Is Mediated by Yes‐Associated Protein 1 Activation and Transient Expansion of Stem‐Like Cancer Cells
Induction of neoangiogenesis is a hallmark feature during disease progression of hepatocellular carcinoma (HCC). Antiangiogenetic compounds represent a mainstay of therapeutic approaches; however, development of chemoresistance is observed in the majority of patients. Recent findings suggest that tu...
Na minha lista:
Main Authors: | , , , , , , , , , , , , , , , , |
---|---|
格式: | Artigo |
語言: | Inglês |
出版: |
Wiley
2022-05-01
|
叢編: | Hepatology Communications |
在線閱讀: | https://doi.org/10.1002/hep4.1869 |
標簽: |
添加標簽
沒有標簽, 成為第一個標記此記錄!
|